Analysed AUTONOMIX MEDICAL INC (AMIX:NASDAQ) News Sources
Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026
08-04-2026
yahoo.com
Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026
22-04-2026
yahoo.com
Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
29-04-2026
yahoo.com
Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
18-05-2026
yahoo.com
Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation
19-05-2026
yahoo.com
Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine
04-06-2026
yahoo.com
What is the current price of AUTONOMIX MEDICAL INC (AMIX:NASDAQ)?
The current price of AUTONOMIX MEDICAL INC (AMIX:NASDAQ) is $6.57.
AUTONOMIX MEDICAL INC (AMIX:NASDAQ) absolute price change since previous trading day?
The absolute price change of AUTONOMIX MEDICAL INC (AMIX:NASDAQ) since the previous trading day is $0.11.
AUTONOMIX MEDICAL INC (AMIX:NASDAQ) percentage price change since previous trading day?
The percentage price change of AUTONOMIX MEDICAL INC (AMIX:NASDAQ) since the previous trading day is 1.7028%.
What is the most recent average sentiment score for AUTONOMIX MEDICAL INC (AMIX:NASDAQ)?
The most recent average sentiment score for AUTONOMIX MEDICAL INC (AMIX:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for AUTONOMIX MEDICAL INC (AMIX:NASDAQ)?
The most recent sentiment for AUTONOMIX MEDICAL INC (AMIX:NASDAQ) is .
SEC-8K** Filing Available For AUTONOMIX MEDICAL INC (AMIX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.